Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M. A. Derbak"'
Autor:
I. O. Khramtsova, M. A. Derbak
Publikováno v:
Ukraïnsʹkij žurnal medicini, bìologìï ta sportu. 6:119-125
The purpose of the study was to determine markers of immune inflammation in patients with nonalcoholic fatty liver disease combined with chronic obstructive pulmonary disease. Materials and methods. The observation revealed 82 patients who were treat
Publikováno v:
Ukraïnsʹkij žurnal medicini, bìologìï ta sportu. 6:91-98
The comorbid diseases can occur at any stage of bronchial obstruction, and, regardless of the severity or phase of chronic obstructive pulmonary disease, significantly affect disability, increase the frequency of hospitalizations, and increase the co
Autor:
M. A. Derbak, A. D. Sitkar
Publikováno v:
Bulletin of Problems Biology and Medicine. 1:131
Publikováno v:
Bulletin of Problems Biology and Medicine. 1:160
Publikováno v:
Вісник проблем біології і медицини, Vol 1, Iss 4, Pp 85--9 (2019)
The widespread distribution of CHC often leads to its combined course with other diseases of the gastrointestinal tract, especially of the upper parts. Aim of the study. To study the frequency of gastroesophageal reflux disease and the prevalence of
Publikováno v:
Bulletin of Problems Biology and Medicine. 3:121
Publikováno v:
Bulletin of Problems Biology and Medicine. 3:153
Publikováno v:
Вісник проблем біології і медицини, Iss 4, Pp 118-121 (2020)
The article presents the results of examination of 479 patients with exacerbation of chronic obstructive pulmonary disease (COPD) during the period 2018 – September 2020. In 46% (218/47479) of patients, stage 2 COPD was diagnosed, in 13% (61/479) o
Publikováno v:
Вісник проблем біології і медицини, Iss 4, Pp 113-117 (2020)
The work shows the possibility of H. pylori (Hp) eradication therapy in patients with chronic hepatitis C (CHC). The aim is to evaluate the efficacy and safety of HP eradication therapy in patients with CHC. The study included 94 patients with chroni